Skip to main content

Table 2 Multivariate analysis of clinical parameters influencing risk of cardiac adverse events

From: Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma

  OR 95% CI P-value
Prior history of cardiac events
 No 1 .045
 Yes 3.48 1.03–12.8
Use of antithrombotic agents
 No 1 .056
 Yes 3.66 0.97–8.79
Duration of PI therapy 1.94 1.21–3.09 .006
  1. Abbreviations: OR odds ratio, CI confidence interval, PI proteasome inhibitor